Search

Current Concepts In Treating Ischemic Foot Ulcers

Clinical Editor: Lawrence Karlock, DPM | 28,740 reads | 0 comments | 03/03/2007

     When it comes to patients with ischemic foot ulcers, potential complications can be dire. Accordingly, it is important to have a firm grasp on diagnostic studies as well as current and emerging treatment options that may enhance outcomes for patients.      With this in mind, our expert panelists discuss a range of issues related to the ischemic foot.      Q: How do you approach/work up the ischemic foot ulcer patient?      A: David E.

Emerging Vascular Approaches For Healing Diabetic Ulcers

By David E. Allie, MD | 11,566 reads | 0 comments | 07/03/2007

Given the severe ramifications associated with the combination of critical limb ischemia (CLI) and diabetic foot ulcers, this author emphasizes the potential impact of revascularization procedures in reducing the number of lower extremity ampulations. Accordingly, he offers a closer looks at recent advances in this arena and their place within the armentarium for CLI It is vital to review the “non-surgical revascularization toolbox” for lower extremity treatments for critical limb ischemia (CLI).

Here one can see a diabetic foot ulcer (DFU). Peripheral arterial disease is cited by the panelists as a key risk factor for the development of these ulcers. The panelists emphasize the importance of a multidisciplinary team in preventing DFUs.

Examining The Evidence For Preventing Diabetic Foot Ulcers

Clinical Editor: Lawrence Karlock, DPM | 21,010 reads | 0 comments | 03/03/2008

When it comes to patients with diabetes and lower extremity ulcers and complications, what does the evidence-based medicine say about high-risk patients and proactive prevention? These panelists examine risk factors for ulcerations, appropriate screening and offer their thoughts on what works and what does not work in terms of prevention.  

Pertinent Pearls On Grading Diabetic Foot Ulcers

Ronald A. Sage, DPM | 17,399 reads | 0 comments | 03/03/2008

Please click here for the full Continuing Medical Education article: http://www.naccme.com/program/n-234/ Given that ulcers are a common complication for patients with diabetes, it is important to understand the various ulcer grading systems and how they can aid in treatment. This author reviews common classification systems and how to apply them in a clinical setting.

Fifteen Percent Of Diabetics Will Develop Foot Ulcers

hmpadmin | 9,076 reads | 0 comments | 02/03/2002

How prevalent are foot ulcers among patients with diabetes? About 2.4 million diabetes patients, representing 15 percent of the estimated 16 million Americans afflicted with the disease, will develop serious foot ulcers during their lifetimes. In fact, ulcers and other foot complications cause 20 percent of the nearly 3 million hospitalizations related to diabetes every year. John Giurini, DPM, an Associate Professor of Surgery at Harvard University Medical School, reported on these alarming statistics at the recent ACFAS Diabetic Foot Symposium.

How To Treat Diabetic Ulcers With Dermagraft

By Patricia L. Abu-Rumman, DPM, Barbara Aung, DPM, and David G. Armstrong, DPM | 27,648 reads | 1 comments | 03/03/2002

The prevalence of diabetic ulceration is alarmingly high and increasing. Currently, it is between 4 and 10 percent, depending on a host of factors including ethnicity, geographic region and duration of disease. Wounds are clearly associated with infection and a high risk of future amputation. The economic implications are overwhelming to the health care system. As clinicians, we must be able to rapidly identify, access and manipulate the factors necessary for wound healing.

Is HBOT Cost-Effective For Diabetic Foot Ulcers?­­­­­­

Caroline E. Fife, MD, CWS | 17,643 reads | 0 comments | 06/01/2009

   It is estimated that Medicare spends $1.5 billion annually to treat diabetic foot ulcers (DFU).1 The debate continues on the cost effectiveness of immediate amputation in comparison with “conservative treatment” using a variety of modalities.

   The cost of healing a DFU is related to its severity but detailed “cost to heal” data stratified by Wagner grade are sparse. Primary amputation is costly not so much because of the expense of the surgical procedure itself but because of the consequences of amputation (e.g. rehabilitation and institutional care).

Key Insights On Offloading Diabetic Neuropathic Ulcers

Kazu Suzuki, DPM, CWS | 12,585 reads | 0 comments | 06/26/2009

   Offloading a wound is a critical component of facilitating optimal outcomes with healing. Accordingly, these expert panelists discuss the use of total contact casting (TCC) to offload diabetic neuropathic wounds as well as the impact of instant total contact casting (iTCC) and other offloading methods.

   Q: As far as offloading devices go for diabetic/neuropathic foot ulcers, do you use total contact casting?

Essential Insights On Treating Diabetic Heel Ulcers

Desmond Bell, DPM | 62,014 reads | 0 comments | 02/23/2010

Diabetic heel ulcers are particularly challenging to treat as a wide range of factors can affect potential healing. With this in mind, this author discusses the challenges of wound bed preparation, key considerations with offloading and the possible impact of peripheral arterial disease.

   Despite a better understanding and the advent of preventive measures that have been developed to address heel ulcers, the problems we encounter due to complications of diabetes make treating this specific patient population more challenging.

Current Concepts In Offloading Diabetic Foot Ulcers

Ryan H. Fitzgerald, DPM | 17,199 reads | 1 comments | 08/24/2009

   As the prevalence of diabetes mellitus increases worldwide, there will be a concomitant increase in the development of the lower extremity manifestations of the disease process. In the United States alone, there are currently an estimated 24 million patients living with diabetes.1,2 Given the reported 15 percent lifetime incidence for the development of lower extremity ulcerations in this patient population, this equates to approximately 3.6 million diabetic foot ulcers (DFUs).3